Giovanelli, L.
Aresta, C.
Favero, V.
Bonomi, M.
Cangiano, B.
Eller-Vainicher, C.
Grassi, G.
Morelli, V.
Pugliese, F.
Falchetti, A.
Gennari, L.
Scillitani, A.
Persani, L.
Chiodini, I. http://orcid.org/0000-0001-7594-3300
Article History
Received: 24 September 2020
Accepted: 7 December 2020
First Online: 4 January 2021
Compliance with ethical standards
:
: All authors declare no support from any organization for the submitted work. Luca Giovanelli, Vittoria Favero, Marco Bonomi, Biagio Cangiano, Cristina Eller-Vainicher, Giorgia Grassi, Valentina Morelli, Flavia Pugliese, Alberto Falchetti, Luigi Gennari, Alfredo Scillitani and Luca Persani, have no financial relationships with any organizations that might have an interest in the submitted work in the previous 3 years and no other relationships or activities that could appear to have influenced the submitted work. Iacopo Chiodini, Carmen Aresta and Valentina Morelli are investigators in studies on relacorilant (Corcept Therapeutics) in patients with hypercortisolism. Iacopo Chiodini received consulting fees from Corcept Therapeutics and HRA Pharma.